PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PATH vs. OPRA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PATH and OPRA is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

PATH vs. OPRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UiPath Inc. (PATH) and Opera Limited (OPRA). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember2025
6.37%
49.33%
PATH
OPRA

Key characteristics

Sharpe Ratio

PATH:

-0.75

OPRA:

1.20

Sortino Ratio

PATH:

-0.78

OPRA:

2.07

Omega Ratio

PATH:

0.88

OPRA:

1.23

Calmar Ratio

PATH:

-0.45

OPRA:

1.04

Martin Ratio

PATH:

-0.91

OPRA:

5.08

Ulcer Index

PATH:

43.54%

OPRA:

12.52%

Daily Std Dev

PATH:

53.02%

OPRA:

52.84%

Max Drawdown

PATH:

-87.61%

OPRA:

-72.85%

Current Drawdown

PATH:

-84.29%

OPRA:

-29.69%

Fundamentals

Market Cap

PATH:

$7.35B

OPRA:

$1.60B

EPS

PATH:

-$0.16

OPRA:

$1.80

Total Revenue (TTM)

PATH:

$1.41B

OPRA:

$347.75M

Gross Profit (TTM)

PATH:

$1.17B

OPRA:

$182.52M

EBITDA (TTM)

PATH:

-$163.23M

OPRA:

$184.21M

Returns By Period

In the year-to-date period, PATH achieves a 5.19% return, which is significantly higher than OPRA's -2.71% return.


PATH

YTD

5.19%

1M

-4.91%

6M

6.36%

1Y

-39.47%

5Y*

N/A

10Y*

N/A

OPRA

YTD

-2.71%

1M

-7.86%

6M

49.33%

1Y

68.67%

5Y*

26.17%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PATH vs. OPRA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PATH
The Risk-Adjusted Performance Rank of PATH is 1717
Overall Rank
The Sharpe Ratio Rank of PATH is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of PATH is 1515
Sortino Ratio Rank
The Omega Ratio Rank of PATH is 1313
Omega Ratio Rank
The Calmar Ratio Rank of PATH is 2020
Calmar Ratio Rank
The Martin Ratio Rank of PATH is 2828
Martin Ratio Rank

OPRA
The Risk-Adjusted Performance Rank of OPRA is 8282
Overall Rank
The Sharpe Ratio Rank of OPRA is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of OPRA is 8383
Sortino Ratio Rank
The Omega Ratio Rank of OPRA is 7878
Omega Ratio Rank
The Calmar Ratio Rank of OPRA is 8181
Calmar Ratio Rank
The Martin Ratio Rank of OPRA is 8383
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PATH vs. OPRA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for UiPath Inc. (PATH) and Opera Limited (OPRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PATH, currently valued at -0.75, compared to the broader market-2.000.002.00-0.751.20
The chart of Sortino ratio for PATH, currently valued at -0.78, compared to the broader market-4.00-2.000.002.004.00-0.782.07
The chart of Omega ratio for PATH, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.23
The chart of Calmar ratio for PATH, currently valued at -0.45, compared to the broader market0.002.004.006.00-0.451.04
The chart of Martin ratio for PATH, currently valued at -0.91, compared to the broader market-30.00-20.00-10.000.0010.0020.00-0.915.08
PATH
OPRA

The current PATH Sharpe Ratio is -0.75, which is lower than the OPRA Sharpe Ratio of 1.20. The chart below compares the historical Sharpe Ratios of PATH and OPRA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
-0.75
1.20
PATH
OPRA

Dividends

PATH vs. OPRA - Dividend Comparison

PATH has not paid dividends to shareholders, while OPRA's dividend yield for the trailing twelve months is around 4.43%.


TTM20242023
PATH
UiPath Inc.
0.00%0.00%0.00%
OPRA
Opera Limited
4.43%4.22%9.07%

Drawdowns

PATH vs. OPRA - Drawdown Comparison

The maximum PATH drawdown since its inception was -87.61%, which is greater than OPRA's maximum drawdown of -72.85%. Use the drawdown chart below to compare losses from any high point for PATH and OPRA. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-84.29%
-29.69%
PATH
OPRA

Volatility

PATH vs. OPRA - Volatility Comparison

UiPath Inc. (PATH) has a higher volatility of 12.69% compared to Opera Limited (OPRA) at 10.79%. This indicates that PATH's price experiences larger fluctuations and is considered to be riskier than OPRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
12.69%
10.79%
PATH
OPRA

Financials

PATH vs. OPRA - Financials Comparison

This section allows you to compare key financial metrics between UiPath Inc. and Opera Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab